Catalyst Wire Dossier Catalyst Wire Dossier

VHL peptide vaccine

tumor-specific mutated VHL peptides · National Cancer Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VHL peptide vaccine, covering 2012-06-14 to 2012-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma [Phase 2]

See pricing